世界のがん光線力学療法市場(~2026):臨床試験インサイト

◆英語タイトル:Global Cancer Photodynamic Therapy Market and Clinical Trial Insight 2026
◆商品コード:KUIK21FB016
◆発行会社(リサーチ会社):Kuick Research
◆発行日:2020年3月
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD2,400 ⇒換算¥273,600見積依頼/購入/質問フォーム
Multi UserUSD4,500 ⇒換算¥513,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKuick Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Kuick Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートでは、世界のがん光線力学療法市場について調査・分析を行い、イントロダクション、癌治療のための光線力学療法の必要性、がん治療用フレームワーク、光線力学療法の有効性、光線力学療法の抗腫瘍活性、光線力学療法を用いた複数のがん治療、光線力学療法の併用、臨床パイプライン概要、がん用光増感剤、市場動向、今後の展望、競争状況などを掲載しています。
・イントロダクション
・癌治療のための光線力学療法の必要性
・がん治療用フレームワーク
・光線力学療法の有効性
・光線力学療法の抗腫瘍活性
・光線力学療法を用いた複数のがん治療
・光線力学療法の併用
・臨床パイプライン概要
・がん用光増感剤
・市場動向
・今後の展望
・競争状況
【レポートの概要】

“Global Cancer Photodynamic Therapy Market and Clinical Trial Insight 2026″ Report Highlights:

Global Cancer Photodynamic Therapy Market Opportunity: > US$ 4 Billion
Share of Cancer in Photodynamic Therapy: > 40%
US To Dominate Global Photodynamic Therapy Market
Global Cancer Photosensitisers Clinical Pipeline: >10 Photosensitisers In Trials
Marketed Cancer Photosensitisers: >5
US Dominating Global Clinical Trials Landscape: >10 Photosensitisers In Trials

The research report “Global Cancer Photodynamic Therapy Market and Clinical Trial Insight 2026” to represent an interpretation of ongoing trends and strategies of global photodynamic therapy market. The research report concentrates on providing the information about the present state of the therapy in the overall cancer market which will bring to our readers a deep and valuable insight about the current trends and the overall growth and strength of the therapy at regional and global level. The information presented in the report has been compiled and segmented to highlight the important achievements and the abilities of the market over the other cancer markets.

The therapy majorly focuses on the treatment of the cancer through the agents that are light sensitive. Since its entry in the cancer market, the therapy is observing a huge commercial success. Being a modern and non-invasive therapeutic modern method, the therapy is constantly adding the number of the patients it is treating. The major growth attributer for the market is the fact that the therapy is totally harmless and utilizes only a source of light for processing necrosis in cancer cells.

Cancer photodynamic therapy holds other additional benefits than the traditional cancer treatments like chemotherapy or surgery. The therapy gives an advantage for suitable mode of administration for the cancer agent, thus ignoring the other harmful scenarios that other therapies makes the cancer patient undergo. The agents involved in the therapy can be administered systematically as well as topically. This makes the therapy a priority among the cancer patients. On the basis of priority and the additional benefits the therapy provides, the market of the therapy has presented a scenario which is a boon for the pharmaceutical companies investing in the respective therapy.

Cancer photodynamic treatment is capable of destructing the cancer cells with just one source of light. This makes the treatment a modern, harmless and a convenient therapy. With so many expertise working on the therapy, so far they have discovered the potential outcomes of the therapy in several medical fields such as urology, cardiology, dentistry, immunology, ophthalmology and most importantly dermatology.

In addition to the benefits it has provided the cancer patients in the last few decades, the therapy is continuously being explored for rest of the cancer fields. The level of the successful cancer survival rates with the discovery of photodynamic therapy has experienced a major growth. The need of the effective cancer treatments has already pushed the researchers to think out of the box and photodynamic therapy out of all the other methodologies is a discovery that has gained enough appreciation in a short period of time. The urgency in reducing the cancer mortality rate and providing an effective yet harmless therapy is what will drive the market of the therapy in the future years.

【レポートの目次】

What is Photodynamic Cancer Therapy?

1.1 Overview
1.2 Advantage of Photodynamic Cancer Therapy
1.3 Evolution of the Photodynamic Cancer Therapy

Why There Exist Need for Photodynamic Therapy For Cancer Treatment?

The Procedural Framework For Photodynamic Cancer Therapy

3.1 Procedure for Photodynamic Therapy
3.2 Administering Photosensitizers To Body
3.3 Oxygen – The Vital Substrate in Photodynamic Therapy
3.4 Light Source – For Safe and Effective Activation of the Photosensitizer

Improving The Photodynamic Therapy Efficacy Through Photosensitizer Delivery

4.1 Role of Organic Nano Particles: Amplified Drug Loading and Increasing The Solubility
4.2 Inorganic Nanocarrier of Photosensitizers in Photodynamic Therapy

Anti-Tumor Activity of the Photodynamic Therapy

5.1 Direct Tumor Photodynamic Therapy Damage
5.2 Vascular Damage
5.3 Inflammatory and Immune Response

Multiple Cancer Treatments Using Photodynamic Therapy

6.1 Non-Melanoma Skin Cancer
6.2 Prostate Cancer
6.3 Breast Cancer
6.4 Brain Tumor
6.5 Lung Cancer
6.6 Head and Neck Cancer
6.7 Oral Lesions and Oesophageal Cancer
6.8 Cervical Cancer
6.9 Colorectal Cancer
6.10 Cancer of the Bile Duct and the Pancreas

Combinational Photodynamic Cancer Therapy – Step Towards Complete Eradication Of Tumor Growth

Advancements in the Photodynamic Therapy Segment

8.1 Intracellular “Activated” Two-Photon photodynamic Therapy for Breast Cancer
8.2 Gold Nano-Clusters: A New Nanotech Innovation for Photodynamic Therapy.
8.3 Photodynamic Therapy and Combinational Therapy using Microbial Adjuvants and Cytokines

Global Cancer Photosensitisers Clinical Pipeline Overview

9.1 By Phase
9.2 By Country
9.3 By Company

Global Cancer Photosensitisers Clinical Pipeline By Company, Indication and Phase

10.1 Research
10.2 Preclinical
10.3 Phase-II
10.4 Phase-III

Marketed Cancer Photosensitisers By Company and Indication

11.1 Ameluz
11.2 UVADEX
11.3 Photobarr/ Photofrin
11.4 Foscan
11.5 Cevira
11.6 Metvix
11.7 TOOKAD Soluble
11.8 Aptocine/ Laserphyrin/ Leserfin/ Litx

Commercial Information Revealing the Industry In-sights for Photodynamic Therapy

12.1 Advancing the Photodynamic Therapy by a Novel Compound
12.2 Adaption of New Techniques for Making Photodynamic Therapy Effective and More Ceaper
12.3 Replacing Oxygen Dependent Drugs with More Efficient Compounds
12.4 Researchers Revolutionizing the Era of Surgical Injections into Gels

Global Photodynamic Therapy Market: Current Scenario and its Role in the Oncology Segment

13.1 Global Photodynamic Therapy Market Analysis
13.2 North America
13.3 Europe
13.4 Asia Pacific
13.5 Latin America, Middle East and Africa

Global Photodynamic Cancer Therapy Market Dynamics

14.1 Favorable Parameters for the Growth
14.2 Challenges to Future Market Growth

Global Photodynamic Cancer Therapy Market Future Outlook

Competitive Landscape

16.1 Theralase Technologies
16.2 Dusa Pharmaceuticals
16.3 Biofrontera AG
16.4 Soligenix
16.5 Coherent
16.6 Lumenis
16.7 Nanoprobes
16.8 PhotoMedex
16.9 Biolitec
16.10 Ambicare Health
16.11 Quest Pharma Tech
16.12 Photolitec



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のがん光線力学療法市場(~2026):臨床試験インサイト]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆